Abexxa Biologics, Inc. — Form D

Abexxa Biologics, Inc. of ARLINGTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-19. The offering totals $1.7M, of which $1.2M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2016-09-19
• Form: D
• Accession: 0001684213-16-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $1.7M
• Amount sold: $1.2M
• Remaining: $500K
• Investors: 3
• Date of first sale: 2016-09-07
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-270910

Issuer

• Name: Abexxa Biologics, Inc.
• CIK: 0001684213
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: NANOFAB BUILDING, 500 S. COOPER ST., ARLINGTON, TX, 76019
• Phone: 512-497-5742

Officers, directors & promoters (5)

More

• CIK 1684213 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search